Solvay Pharma India Ltd(merged)

Solvay Pharma. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Solvay Pharma India Ltd(merged)

₹ None%
- close price
solvaypharma.co.in
About

Solvay Pharma India Limited(merged), incorporated in India, listed on the Bombay Stock Exchange, the company is engaged in tablets, capsules, syrups, etc.

[ add key points ]
Website
  • Market Cap ₹ Cr.
  • Current Price ₹
  • High / Low ₹ /
  • Stock P/E
  • Book Value ₹
  • Dividend Yield %
  • ROCE 51.2 %
  • ROE 34.4 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 22.8% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 33.5%
  • Company has been maintaining a healthy dividend payout of 31.1%
  • Debtor days have improved from 25.1 to 18.6 days.

Cons

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Operating Profit
OPM %
Interest
Depreciation
Profit before tax
Tax %
EPS in Rs
Raw PDF

Profit & Loss

Figures in Rs. Crores

Dec 2005 Dec 2006 Dec 2007 Dec 2008 Dec 2009 Dec 2010
130 144 167 202 242 295
99 113 123 156 183 222
Operating Profit 30 31 44 46 59 73
OPM % 23% 21% 26% 23% 24% 25%
3 4 4 6 5 6
Interest 0 0 0 0 0 0
Depreciation 5 5 5 1 3 3
Profit before tax 28 30 43 50 61 76
Tax % 36% 37% 34% 35% 34% 33%
18 19 28 33 40 51
EPS in Rs
Dividend Payout % 17% 22% 72% 27% 41% 25%
Compounded Sales Growth
10 Years: %
5 Years: 18%
3 Years: 21%
TTM: 22%
Compounded Profit Growth
10 Years: %
5 Years: 23%
3 Years: 22%
TTM: 30%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: 32%
3 Years: 33%
Last Year: 34%

Balance Sheet

Figures in Rs. Crores

Dec 2005 Dec 2006 Dec 2007 Dec 2008 Dec 2009 Dec 2010
Equity Capital 5 5 5 5 5 5
Reserves 63 77 82 104 125 161
0 0 0 0 0 0
21 26 32 48 41 54
Total Liabilities 89 108 119 157 172 220
10 7 4 2 38 36
CWIP 0 0 0 35 0 0
Investments 7 14 40 17 16 37
72 87 74 103 118 148
Total Assets 89 108 119 157 172 220

Cash Flows

Figures in Rs. Crores

Dec 2005 Dec 2006 Dec 2007 Dec 2008 Dec 2009 Dec 2010
17 15 27 -7 70 27
-6 -6 -24 1 -9 -17
-3 -4 -19 -12 -15 -12
Net Cash Flow 8 6 -17 -17 46 -2

Ratios

Figures in Rs. Crores

Dec 2005 Dec 2006 Dec 2007 Dec 2008 Dec 2009 Dec 2010
Debtor Days 36 36 36 33 24 19
Inventory Days 113 136 118 240 116 165
Days Payable 94 107 89 134 74 87
Cash Conversion Cycle 56 65 66 140 66 96
Working Capital Days 44 47 34 82 33 49
ROCE % 39% 51% 51% 50% 51%

Shareholding Pattern

Numbers in percentages

Shareholding pattern is currently not available for this company.

Documents

Announcements

All

No data available.

Annual reports

No data available.